The present invention relates to a marker for predicting abnormal pregnancy results in high-risk pregnant women having systemic lupus erythematosus, an abnormal pregnancy risk evaluation method using the same, or a kit for diagnosing abnormal pregnancy using the same. The present invention includes the steps of: quantifying the levels of lysophosphatidylcholine and tryptophan in biological samples isolated from a pregnant woman with systemic lupus erythematosus; and evaluating the risk of abnormal pregnancy of the pregnant woman.
Method for assessing Pregnancy Risk of Systemic lupus erythematosus Mother